According to FutureWise analysis, the PSA test market in 2025 is US$4.23 billion and is expected to reach US$8.05 billion by 2033, at a CAGR of 8.28%. The growth of the prostate-specific antigen (PSA) test market is primarily driven by increasing awareness of prostate cancer screening and advancements in diagnostic technologies. The rising prevalence of prostate-related disorders among aging populations is also contributing to demand. Additionally, the expansion of healthcare infrastructure and the adoption of early detection practices in emerging economies are expected to significantly enhance market growth. The PSA test, a blood test used mainly for screening prostate cancer, checks for prostate-specific antigen (PSA) levels in the blood. PSA is a protein produced by both cancerous and noncancerous cells in the prostate gland, which lies just below the bladder in men. While a small amount of PSA is normally present in the blood, elevated levels may indicate the presence of prostate cancer. However, other conditions, such as an enlarged or inflamed prostate, can also lead to increased PSA levels, making interpretation of the results challenging. In the coming years, the growing elderly population is poised to further boost the PSA test market. Prostate cancer screening offers several advantages, including the ability to detect tumors that are likely to spread and a reduction in mortality risk from prostate cancer. These benefits contribute to the increasing public awareness and forward momentum of the PSA test market. Furthermore, technological advancements in prostate cancer testing and treatment, along with the availability of reimbursement policies for prostate cancer therapies, are expected to influence the growth of the PSA test market in the near future.

FutureWise Market Research has instantiated a report that provides an intricate analysis of PSA Test Market trends that shall affect the overall market growth.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=9809&type=requestsample

By Type

• CLIA
• ELISA
• Others

By Applications

• Screening
• Post-treatment Monitoring
• Others
• Wholesale

• • Retail (in-store)
  • Distributors/ Franchises

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in PSA Test Market:

• Abbott
• Siemens Healthcare
• DiaSorin
• Roche
• Beckman Coulter
• PerkinElmer
• Tosoh
• Ortho Clinical
• Fujirebio
• Mediwatch
• BodiTech

Recent developments by key players in the PSA Test Market:

Siemens Healthineers

• Strategic Acquisitions: In April 2025, Siemens Healthineers acquired the U.S.-based R&D scientific software company Dotmatics for $5.1 billion. This acquisition aims to enhance its Life Sciences portfolio and integrate AI-powered product lifecycle management software within its Xcelerator platform.

DiaSorin

• Financial Performance: In the first half of 2025, DiaSorin reported a 3% growth in its Ex-COVID Molecular Diagnostics segment, which includes PSA testing. The company credits this growth to its "Legacy DiaSorin" tests and the positive impact of the multiplexing business

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9809&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the PSA Test Market By Type, By Applications and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com